FPD/AML is an inherited platelet disorder caused by germline RUNX1 mutation and characterized by thrombocytopenia, platelet function defect and leukemia predisposition. The mechanisms underlying FPD/AML platelet dysfunction remain incompletely clarified. We aimed to determine the contribution of platelet structural abnormalities and defective activation pathways to the platelet phenotype. In addition, by using a candidate gene approach, we sought to identify potential RUNX1-regulated genes involved in these defects.
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Measurements were performed in duplicate. To determine PAC-1 or fibrinogen binding, MFI obtained after binding to unstimulated platelets was substracted from MFI obtained in activated platelets, whereas P-selectin was expressed as percentage of platelets positive for this marker. For comparison between measurements conducted on different days, MFI was normalized according to variation in control samples and expressed as mean fluorescence units (MFU) .
Electron microscopy of platelets
To evaluate platelet ultrastructure, PRP was fixed with 5% glutaraldehyde in 0.1M phosphate buffer, pH 7.2, rinsed, postfixed in 1% osmium tetroxide in the same buffer and embedded in Araldite (Sigma-Aldrich, St Louis, MO, USA). Thin sections were stained with uranyl acetate (Riedel-d Haen, AG, Germany) and lead citrate (Sigma-Aldrich) and examined in a transmission electron microscope (Zeiss, EM 900, Germany).
Immunofluorescence analysis for thrombospondin-1
Platelet thrombospondin-1 (TSP1) content was assessed on blood smears by immunostaining with mouse anti-TSP1 antibody (Sigma-Aldrich) followed by FITCconjugated goat anti-mouse antibody. Platelets were identified by F-actin labeling with tetramethyl rhodamine isothiocyanate (TRITC)-conjugated phalloidin (Sigma-Aldrich) and at least 200 platelets were examined under a fluorescence microscope (Zeiss Axiostar Plus, Göttingen, Germany) by two independent observers. For analysis, platelets were classified according to the number of TSP1-positive granules into platelets displaying >5 granules and those with ≤5 granules, as described [18, 19] .
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Platelet spreading
To assess platelet spreading, 5x10 7 /mL platelets were plated on glass coverslips coated with 100 ug/mL human fibrinogen (Sigma-Aldrich) during 30 min. at RT. Adherent platelets were fixed, permeabilized and stained with FITC-labelled phalloidin (Sigma-Aldrich). At least 200 platelets were analyzed by two different examiners under a fluorescence microscope and classified as round, filopodia-bearing or platelets with lamellipodia extension.
Tyrosine phosphorylation of β 3 integrin in platelets
To study β3 integrin phosphorylation, 6-well polystyrene plates were coated with 100 ug/mL human fibrinogen and blocked with 1% bovine serum albumin (BSA). Washed platelets (3x10 8 /mL) resuspended in modified Tyrode's buffer containing 1mM CaCl 2 were added and incubated for 60 min. at RT. Nonadherent cells were removed and adherent cells were lysed in RIPA buffer (50mM Tris-HCl, pH=8, 150mM NaCl, 1% Nonidet P-40, 0.1% SDS, 1% sodium deoxycholate). Lysates of non-adherent cells were prepared after plating on 3% BSA-coated plates. After SDS-PAGE, membranes were incubated with rabbit polyclonal anti-phospho integrin β3 (Tyr773) antibody (Abcam, Cambridge, UK) followed by horseradish-peroxidase (HRP)-conjugated antirabbit antibody and enhanced chemiluminescence (ECL) detection. Protein loading was assessed on duplicate membranes with rabbit anti-β3 integrin (Santa Cruz, CA, USA).
Gene expression analysis in platelets
To prepare platelet RNA, PRP was filtered through a leukocyte reduction filter (Purecell PL, Pall Biomedical Products Co, NY), as described [20] , red blood cells were lysed
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This article is protected by copyright. All rights reserved. with 8.6 gr/L ammonium chloride and 1x10 9 platelets were lysed in Trizol (Life Technologies, NY, USA). Expression levels of target genes were assessed in triplicate by real-time PCR relative to GAPDH in an iCycler (Bio Rad Life Science, CA, USA) using SYBR® Green (Life Technologies), primer sequences are listed in Supplementary Table. Serial cDNA dilutions were assessed to ensure similar amplification efficiency of the target and internal control genes.
Western blot analysis of platelet NF-E2 content
Platelet-rich plasma was subjected to leukocyte depletion and red blood cell lysis, as for preparation of platelet RNA, and washed platelets (2 x 10 9 /mL) were lysed, as described [11] , followed by SDS-PAGE. Membranes were probed with anti-NF-E2 rabbit IgG (Santa Cruz Biotechnologies), followed by HRP-conjugated secondary antibody and ECL detection and then reprobed with mouse anti-β-actin (Sigma Aldrich). A ratio between NF-E2 and β-actin calculated by densitometry was expressed as percentage of mean ratio of normal controls assayed on the same blot, set as 100%. Mean values from two different experiments were calculated.
Chromatin Immunoprecipitation (ChIP) and promoter activity assays
ChIP assays were performed with a ChIP assay kit (Millipore Upstate Biotechnology, Billerica, MA, USA) using anti-RUNX1 antibody (ab23980, Abcam). Assays were performed using chromatin prepared from human megakaryocytes, as previously described [21] . Immunoprecipitated DNA was analyzed on a PRISM® 7700 sequence detection system using SYBR® Green (Applied Biosystems, Saint-Aubin, France) in duplicate. Two independent experiments were performed. Promoter activity assays were performed in HEL cells, as previously described [21] . Primer sequences are listed in Supplementary Table. Accepted Article This article is protected by copyright. All rights reserved.
Statistical analysis

Comparison between patients and controls was performed using Student´s t-test or
Mann-Whitney-Wilcoxon test, as appropriate. Variables were analyzed for normality and equality of variances using Shapiro-Wilks and F-test, respectively. To account for variability in experimental conditions among flow cytometry measurements performed on different days, control and patient samples handled in parallel were analyzed as pairs using paired t-test. P values < 0.05 were considered significant. Analysis was performed with InfoStat (Universidad Nacional de Córdoba, Argentina) and GraphPad Prism 5 (La Jolla, CA, USA) software.
Results
Light transmission aggregometry and dense granule content and release
Platelet aggregation tests showed marked abnormalities in response to standard concentrations of ADP, epinephrine, collagen and arachidonic acid ( Fig. 1 ), while response to ristocetin was largely preserved. Tests were performed on two to three occasions for each patient and mean values are depicted in Table 2 . As shown, response to epinephrine and collagen was always severely impaired or absent, while aggregation traces in response to ADP and arachidonic acid were more variable among affected family members or during sequential evaluation in the same patient, ranging from severe decrease in primary wave to preserved primary response with lack of secondary aggregation. ATP release triggered by 2µM ADP was severely decreased or absent (Table 2) , while ATP secretion in response to 1mM arachidonic acid was absent in PII.2 and PIII.3 and decreased in PII.1, who also showed absent ATP release in response to 1µM epinephrine (data not shown). Mepacrine uptake was reduced in patients (n=4) compared to controls (n=4), 0.61±0.21 vs. 1.00±0.26 MFU, P= 0.028, paired t-test, indicating that, besides impaired dense granule secretion, there is a
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Assessment of α IIb β 3 integrin activation
Agonist binding to their platelet receptors triggers inside-out signaling events that lead to α IIb β 3 integrin conformational change and exposure of binding sites for fibrinogen. To assess the contribution of impaired α IIb β 3 integrin activation to defective platelet aggregation, both PAC-1 and fibrinogen binding were evaluated. PAC-1 binding to platelets stimulated with 10µM ADP was decreased in patients compared to controls, 0.58±0.1 vs. 1.00±0.17 MFU, P= 0.01, paired t-test ( Fig 
Electron microscopy of platelets
To evaluate whether RUNX1 germline mutation leads to platelet structural abnormalities, electron microscopy was performed for two patients revealing heterogeneity in platelet size and shape, disorganized submembrane microfilaments and distended open canalicular system with vacuolated appearance. Marked decrease in the number of dense granules was found, while α-granule content was heterogeneous, as some platelets were completely devoid of granules, while others showed normal or near normal α-granule content (Fig. 3 ).
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Immunofluorescence for α-granule marker Thrombospondin-1 and P-selectin expression
In order to quantify α-granules, immunofluorescence labeling for TSP1 was performed.
Five or less than 5 α granules per platelet was used as a stringent cut-off value for αgranule deficiency, as reported [18, 19, 22] . A mild but significant increase in the percentage of platelets with severe α-granule reduction was found in patients compared to controls, 15±2.3% vs. 3.1±1%, p=0.03, Mann-Whitney-Wilcoxon test ( Fig.   4A and B). Platelet activation leads to redistribution of P-selectin from α-granule membranes to the platelet surface, representing a marker for α-granule degranulation. P-selectin expression induced by 20µM ADP was decreased in patients (n=4) compared to controls (n=4), 38.7±16.8 vs. 68.5±16%, P= 0.008, paired t-test.
Outside-in signaling responses
Next, we explored whether abnormal outside-in mechanisms contribute to defective hemostasis in these patients. Fibrinogen binding to α IIb β 3 triggers downstream signaling cascades that stabilize the platelet aggregate and trigger cytoskeleton reorganization leading to cell spreading, filopodia and lamellipodia formation. Morphologic analysis of platelets adherent to fibrinogen revealed an increased percentage of platelets remaining round or displaying only filopodia, together with a decrease in platelets showing lamellipodia in patients compared to controls, 17.5±11.5 vs. 0.9±0.5, 29.4±10.2 vs. 12.4±3 and 53±16.3 vs. 86.6±1.95%, respectively, although the difference for each parameter was not statistically significant ( Fig. 5A and B ).
Fibrinogen ligation leads to tyrosine phosphorylation of β3 subunit cytoplasmatic tail and downstream signaling substrates. Phosphorylation of β 3 integrin was impaired in patient platelets adherent to immobilized fibrinogen compared to control platelets (Fig.   5C ).
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Expression of candidate RUNX1-targets in platelets
To identify candidate RUNX1-targets with a possible role in the platelet functional defects, we first assessed gene expression levels of transcription factor p45 NF-E2, which plays a key role in platelet function [23] , being essential for α IIb β 3 inside-out signaling [24] and for development of normal granule content [25] . Both NF-E2 1A and 1F transcripts were measured, which lead to the same protein but are regulated by alternative promoters [26] . We found a reduction in both isoforms, which, although potentially biologically relevant, did not reach statistical significance (Fig. 6A ). To determine if reduced gene expression of NF-E2 led to decreased protein levels, we assessed NF-E2 content by Western blot in platelet lysates. A consistent reduction in NF-E2 was found in three evaluated FPD/AML patients, ranging from 33 to 62% of control levels (Fig. 6B) , confirming that NF-E2 is downregulated in FPD/AML. Next, we studied downstream NF-E2 effectors with a possible role in the platelet phenotype.
Concerning NF-E2 target genes likely to be involved in defective granule biogenesis, we found a trend towards reduced levels of RAB27B, which regulates intracellular vesicle trafficking and dense granule packaging [27, 28] , Fig. 6A . With regards to NF-E2-regulated genes implicated in inside-out α IIb β 3 activation, levels of Rap1 guanine nucleotide exchange factor CALDAG-GEFI, which represents a critical step in agonistinduced integrin activation [29, 30] , were normal ( Fig.6A ), while platelet expression of alternative NF-E2 candidate targets with a role in α IIb β 3 activation, including caspase 12
[31] and thiol isomerase ERP5 [23, 32], was below the detection limit of our assay (data not shown). Besides, we confirmed a profound reduction in RUNX1-target MYL9 in platelets, (Fig. 6A ), as already described in FPD/AML samples [10, 12] .
Chromatin Immunoprecipitation (ChIP) and promoter activity assays
To address whether NF-E2 is a direct transcriptional target of RUNX1, we performed
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Regarding mechanisms underlying platelet dysfunction, we found decreased dense granule content by both mepacrine staining and electron microscopy, confirming previous findings in other FPD/AML pedigrees [4-7]. In addition, analysis of platelet ultrastructure revealed heterogeneous α-granule content and immunofluorescence for α-granule marker TSP1 confirmed the partial reduction in α-granules. Therefore, although combined α and δ granule deficiency was found, while δ granules were markedly and uniformly decreased, the reduction in α granules was variable, as described for patients with combined αδ storage pool deficiency (SPD). In agreement with our findings, partial α granule plus dense granule deficiency has been previously reported in another FPD/AML pedigree [35, 36] . Study of additional patients will be required to establish the significance of α-granule deficiency in FPD/AML and its potential contribution to the defect in hemostasis. In addition, defective αIIbβ3 integrin activation was shown, indicating that impaired inside-out signaling represents an additional mechanism involved in platelet dysfunction. Abnormal αIIbβ3 activation has been previously reported for another FPD/AML patient, although in this case, dense granule content was normal and platelet dysfunction was proposed to rely solely on decreased αIIbβ3 function [8] . The finding that both SPD and impaired αIIbβ3 activation contribute to this phenotype highlights the complexity of FPD/AML platelet function defect.
To search for RUNX1-targets potentially involved in these specific abnormalities, i.e. SPD and impaired αIIbβ3 activation, we focused in transcription factor p45 NF-E2, which besides regulating terminal megakaryocyte maturation and proplatelet formation, plays a key role in both granule biogenesis and inside-out signaling. NF-E2 knockout mice display profound thrombocytopenia and megakaryocytes show a late arrest in maturation together with a striking granule deficiency [25] and failure to bind fibrinogen in response to agonists [24] . However, the virtual absence of platelets precludes the study of platelet function in this model. More recently, the essential role of NF-E2 in
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